Cody joined Ambria Capital in 2019 and serves as a Managing Partner.
Cody manages market assessment projects and due diligence, as well as client relationships. He oversees one of the most active due diligence programs in the psychedelics industry, focused on early-stage companies and non-traditional venture opportunities.
Cody is passionate about advocating for psychedelic-assisted therapies and advancing their place in the mental healthcare landscape. To date, he and his team have backed more than 50 companies and supported many in growth to scale. Cody was recently recognized and honored as the 2021 Investor of the Year at the 1st Annual Microdose Awards.
Cody is a frequent podcast guest and panelist at leading industry conferences. He currently resides in Southern Florida with his wife and son.